Vortrag am FONDS professionell KONGRESSUBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
| MVD-Fonds Rating | EDA |
|---|---|
  | 74 |
ISIN: LU0069152568 | WKN: 986327
KAG: UBS AM S.A. (EU)
NAV: 910,31 USD am 11.02.2026
Portfolio
Watchlist
KursalarmChart
Kennzahlen UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +1,29% | +33,92% | +35,81% | +29,68% | +7,92% | +121,49% | +810,31% |
| Volatilität | +23,18% | +19,16% | +22,02% | +20,27% | +21,74% | +23,23% | +26,94% |
| Sharpe Ratio | +0,64 | +3,99 | +1,54 | +0,35 | -0,02 | +0,27 | +0,22 |
| Bester Monat | - | +10,25% | +10,25% | +15,82% | +15,82% | +15,82% | +41,13% |
| Schl. Monat | - | -1,52% | -6,59% | -8,90% | -11,66% | -13,55% | -28,27% |
| Max. Verlust | -5,27% | -5,27% | -20,01% | -29,34% | -36,42% | -36,42% | -75,23% |
Monatsperformance UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
| 2026 | 2025 | 2024 | 2023 | 2022 | |
| Januar | +2,79% | +8,24% | -2,87% | +1,32% | -11,66% |
| Februar | -0,20% | -4,31% | -0,65% | -6,03% | -2,71% |
| März | - | -6,59% | +1,77% | +0,80% | +4,10% |
| April | - | +1,58% | -8,43% | +0,63% | -9,90% |
| Mai | - | -3,68% | +9,18% | -2,75% | -3,91% |
| Juni | - | +6,13% | +3,78% | +1,04% | +5,86% |
| Juli | - | +4,37% | +6,78% | +2,67% | +1,43% |
| August | - | +5,63% | -4,02% | -2,00% | +5,19% |
| September | - | +6,88% | -2,07% | -4,14% | -0,31% |
| Oktober | - | +10,25% | -4,35% | -8,90% | +4,72% |
| November | - | +6,02% | +0,58% | +5,02% | +6,94% |
| Dezember | - | -1,52% | -7,70% | +15,82% | -6,14% |
| Gesamt | +2,58% | +36,27% | -9,19% | +1,42% | -8,32% |
